JMJoanna H. Marczak

Joanna H. Marczak

*This is an algorithmically generated author record based on publicly available information.

Joanna H. Marczak has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ASSOCIATION BETWEEN OBESITY AND HYPOTHYROIDISM: A COMPREHENSIVE REVIEW

    by Bianka Błaszkiewicz, Katarzyna Marut, Ksenia Oksana Kobelak, Iga Borejszo, Małgorzata Lubowiecka, Joanna Marczak, Agata Leszek, Natalia Moskwa, Zuzanna Lecyk

    Obesity and hypothyroidism are among the most prevalent chronic disorders worldwide and frequently coexist in clinical practice. Although hypothyroidism has traditionally been regarded as a contributing factor to weight gain because of its effects on basal metabolic rate and energy expenditure, accumulating evidence suggests that obesity itself may substantially influence thyroid function through endocrine, metabolic, and inflammatory mechanisms. This comprehensive review summarizes current evidence regarding the association between obesity and hypothyroidism, focusing on epidemiological findings, pathophysiological mechanisms, thyroid autoimmunity, metabolic phenotypes, pediatric and adult populations, and therapeutic implications. Evidence from systematic reviews, longitudinal cohort studies, Mendelian randomization analyses, and observational investigations indicates that obesity is associated with an increased prevalence of both overt and subclinical hypothyroidism. Adipose tissue-derived mediators, particularly leptin and pro-inflammatory cytokines, appear to influence the hypothalamic–pituitary–thyroid axis, alter peripheral thyroid hormone metabolism, and promote autoimmune thyroid disease. However, mild elevations of thyroid-stimulating hormone observed in many obese individuals, especially children, often represent adaptive physiological responses rather than permanent thyroid dysfunction and frequently normalize following weight reduction. Current evidence further suggests that improving metabolic health and reducing excess body weight have greater effects on thyroid function than thyroid hormone replacement alone in patients without overt hypothyroidism. Overall, the available literature supports a bidirectional but predominantly obesity-driven relationship between obesity and thyroid dysfunction. Understanding these mechanisms may improve diagnostic accuracy, reduce unnecessary pharmacological treatment, and facilitate individualized management strategies for patients presenting with both conditions.

  • IRRITABLE BOWEL SYNDROME IN CHILDREN: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT

    by Agata Leszek, Michał Stermach, Zuzanna Lecyk, Małgorzata Lubowiecka, Natalia Moskwa, Iga B. Borejszo, Joanna H. Marczak, Ksenia Kobielak, Katarzyna Marut, Bianka Błaszkiewicz

    Background Irritable bowel syndrome (IBS) is a chronic disorder of gut brain interaction in children associated with recurrent abdominal pain, altered bowel habits, psychological comorbidities, impaired daily functioning, and reduced quality of life. Aim This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions. Materials and Methods PubMed, Embase, Cochrane Library, and Google Scholar were searched for English language publications from 2010 to 2026. The final search was conducted on June 15, 2026. Fifty studies and guidelines were included in the descriptive synthesis. Results Pediatric IBS has a multifactorial pathogenesis involving disturbances in gut brain communication, visceral hypersensitivity, post infectious mechanisms, alterations in the intestinal microbiota, and psychosocial factors. Diagnosis relies on symptom-based criteria, clinical assessment, and evaluation for alarm features; routine extensive testing is discouraged when alarm features are absent. Management should be individualized and may include education of the child and family, dietary measures, psychological interventions, and symptom directed pharmacotherapy. Cognitive behavioural therapy and gut directed hypnotherapy may reduce symptoms and psychological distress in selected children. Evidence for dietary and pharmacological interventions remains heterogeneous, and microbiome profiles are not established diagnostic biomarkers for routine clinical use. Conclusions Pediatric IBS should be diagnosed clinically and managed according to predominant symptoms, disease severity, psychological comorbidities, and daily functioning. Further pediatric studies are needed to clarify the effectiveness, safety, duration, and optimal sequence of interventions.

  • Open Access

    TREATMENT STRATEGIES FOR POUCHITIS: STEP-UP VERSUS EARLY BIOLOGIC THERAPY

    by Małgorzata Lubowiecka, Anna Szeszko, Zuzanna Lecyk, Agata Leszek, Natalia Moskwa, Iga B. Borejszo, Joanna H. Marczak, Ksenia O. Kobelak, Katarzyna Marut, Bianka A. Błaszkiewicz

    Research objectives: This systematic review aims to assess and summarize the available evidence comparing step-up strategies versus early biologic therapy for pouchitis. The goal is to clarify their relative effectiveness, safety profiles, and impact on clinical outcomes to inform evidence-based treatment algorithms and identify gaps for future research. Methods: A systematic review was conducted using PubMed, Google Scholar, and ResearchGate. Eligible studies included clinical trials, observational studies, systematic reviews, meta-analyses, and international guidelines published after 1990. Search terms combined RPC-IPAA, acute pouchitis, chronic pouchitis, step-up therapy, biologic therapy, antibiotics, immunosuppressants, and advanced therapies. Key findings: Most patients with acute pouchitis treated with antibiotics achieved a short-term clinical response, although relapses and progression to chronic disease were common. Chronic combination antibiotic therapy maintained remission in approximately three-quarters of patients but was associated with bacterial resistance and adverse events. Biologic agents achieved response rates of approximately 60%, while remission remained ≤50%. Vedolizumab and ustekinumab showed higher long-term tolerability and treatment persistence than TNF inhibitors. Evidence of early biologic therapy was limited, and no clear association between early initiation and clinical outcomes was identified. Conclusions: Step-up antibiotic therapy remains justified as the first-line treatment for pouchitis due to its high short-term efficacy. Biologic agents represent a valuable option for chronic or refractory disease but do not appear to be superior to antibiotics as initial treatment. Current evidence does not support routine early biologic therapy for all patients, although selected high-risk groups may benefit. Future prospective studies are needed to define optimal timing of biologic therapy.

  • Open Access

    Inferior Vena Cava-Atrial Anastomosis in Liver Transplant Recipient with Inferior Vena Cava Occlusion: A Case Report and Literature Review

    by Jakub Rochoń, Piotr Kalinowski, Joanna Marczak, Krzysztof Gibiński, Michał Grąt

    A 25-year-old woman with decompensated liver cirrhosis and complete inferior vena cava (IVC) occlusion was referred to our department for liver transplantation. The etiology of cirrhosis was Budd-Chiari syndrome (BCS) related to systemic lupus erythematosus, autoimmune hepatitis, and primary biliary cholangitis (AIH-PBC) overlap syndrome. Transplantation was feasible due to an extensive collateral circulation of pre-vertebral veins that drained blood from the lower extremities and both kidneys to the azygos-hemiazygos veins. This venous anomaly enabled the excision of the obstructed retrohepatic IVC, followed by an alternative anastomosis of the suprahepatic IVC to the right atrium without reconstruction of the infrahepatic IVC. Despite good venous patency and normalization of liver graft function, the patient developed cecum perforation, cardiovascular and respiratory insufficiency, which led to the patient’s death two months after transplantation. This case report supports an individual approach and highlights the feasibility of liver transplantation despite an extensive IVC thrombosis. To our knowledge, it is the first description of the application of a deceased donor liver transplantation in patients with AIH-PBC overlap syndrome and lupus-related BCS. A concise review of published literature on IVC-atrial anastomosis in adult liver transplant recipients is provided, and the technique is discussed based on our recent experience.